FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2020908426> ?p ?o ?g. }

• W2020908426 endingPage "1184" @default.
• W2020908426 startingPage "1175" @default.
• W2020908426 abstract "1. This study characterises some of the mechanisms and mediators involved in the orofacial nociception triggered by injection of formalin into the upper lip of the rat, by assessing the influence of various treatments on behavioural nociceptive responses (duration of facial rubbing) elicited either by a low subthreshold (i.e. non-nociceptive; 0.63%) or a higher concentration of the algogen (2.5%). 2. The kininase II inhibitor captopril (5 mg kg(-1), s.c.) and prostaglandin(PG) E(2) (100 ng lip(-1)) potentiated both phases of the response to 0.63% formalin, whereas tumour necrosis factor (TNF alpha; 5 pg lip(-1)), interleukin(IL)-1 beta (0.5 pg lip(-1)), IL-6 (2 ng lip(-1)) and IL-8 (200 pg lip(-1)), or the indirectly acting sympathomimetic drug tyramine (200 microg lip(-1)), each augmented only the second phase of nociception. 3. Conversely, both phases of nociception induced by 2.5% formalin were inhibited by the bradykinin (BK) B(2) receptor antagonist HOE140 (5 microg lip(-1)) or the selective beta(1)-adrenoceptor antagonist atenolol (100 microg lip(-1)). However, the BK B(1) receptor antagonist des-Arg(9)-Leu(8)-BK (1 and 2 microg lip(-1)), antibody and/or antiserum against each of the cytokines, the adrenergic neurone blocker guanethidine (30 mg kg(-1) day(-1), s.c., for 3 days) and the cyclooxygenase(COX)-2 inhibitor celecoxib (50 and 200 microg lip(-1), s.c.; or 1 and 3 mg kg(-1), i.p.) reduced only the second phase of the response. The nonselective COX inhibitor indomethacin and the 5-lipoxygenase activating protein inhibitor MK886 did not change formalin-induced nociception. 4. Our results indicate that BK, TNF-alpha, IL-1 beta, IL-6, IL-8, sympathetic amines and PGs (but not leukotrienes) contribute significantly to formalin-induced orofacial nociception in the rat and the response seems to be more susceptible to inhibition by B(2) receptor antagonist and selective COX-2 inhibitor than by B(1) receptor antagonist or nonselective COX inhibitor." @default.
• W2020908426 created "2016-06-24" @default.
• W2020908426 creator A5008275837 @default.
• W2020908426 creator A5038787428 @default.
• W2020908426 creator A5091005335 @default.
• W2020908426 date "2004-04-01" @default.
• W2020908426 modified "2023-09-25" @default.
• W2020908426 title "Involvement of bradykinin, cytokines, sympathetic amines and prostaglandins in formalin-induced orofacial nociception in rats" @default.
• W2020908426 cites W1521499119 @default.
• W2020908426 cites W1902187490 @default.
• W2020908426 cites W1904153590 @default.
• W2020908426 cites W191908788 @default.
• W2020908426 cites W1966094030 @default.
• W2020908426 cites W1966612762 @default.
• W2020908426 cites W1966820993 @default.
• W2020908426 cites W1975201050 @default.
• W2020908426 cites W1978515480 @default.
• W2020908426 cites W1979469744 @default.
• W2020908426 cites W1979921010 @default.
• W2020908426 cites W1980601649 @default.
• W2020908426 cites W1980768320 @default.
• W2020908426 cites W1984632338 @default.
• W2020908426 cites W1985491152 @default.
• W2020908426 cites W1987329204 @default.
• W2020908426 cites W1990378054 @default.
• W2020908426 cites W1996512044 @default.
• W2020908426 cites W2001699192 @default.
• W2020908426 cites W2001933690 @default.
• W2020908426 cites W2005098530 @default.
• W2020908426 cites W2007080076 @default.
• W2020908426 cites W2008882321 @default.
• W2020908426 cites W2009345240 @default.
• W2020908426 cites W2011828507 @default.
• W2020908426 cites W2014990551 @default.
• W2020908426 cites W2018965901 @default.
• W2020908426 cites W2020500084 @default.
• W2020908426 cites W2021685361 @default.
• W2020908426 cites W2022577011 @default.
• W2020908426 cites W2034972265 @default.
• W2020908426 cites W2035598134 @default.
• W2020908426 cites W2037752760 @default.
• W2020908426 cites W2040299229 @default.
• W2020908426 cites W2047142489 @default.
• W2020908426 cites W2054195861 @default.
• W2020908426 cites W2054519722 @default.
• W2020908426 cites W2054519973 @default.
• W2020908426 cites W2057060327 @default.
• W2020908426 cites W2065355734 @default.
• W2020908426 cites W2067239929 @default.
• W2020908426 cites W2067916896 @default.
• W2020908426 cites W2069824549 @default.
• W2020908426 cites W2075848324 @default.
• W2020908426 cites W2075943879 @default.
• W2020908426 cites W2083748640 @default.
• W2020908426 cites W2088163920 @default.
• W2020908426 cites W2088213242 @default.
• W2020908426 cites W2099060357 @default.
• W2020908426 cites W2105070448 @default.
• W2020908426 cites W2116142178 @default.
• W2020908426 cites W2117558614 @default.
• W2020908426 cites W2132744991 @default.
• W2020908426 cites W2133316133 @default.
• W2020908426 cites W2135745523 @default.
• W2020908426 cites W2136089911 @default.
• W2020908426 cites W2229863986 @default.
• W2020908426 cites W2252978673 @default.
• W2020908426 cites W2410783293 @default.
• W2020908426 cites W2413190521 @default.
• W2020908426 cites W4205205260 @default.
• W2020908426 doi "https://doi.org/10.1038/sj.bjp.0705724" @default.
• W2020908426 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/1574892" @default.
• W2020908426 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/15006904" @default.
• W2020908426 hasPublicationYear "2004" @default.
• W2020908426 type Work @default.
• W2020908426 sameAs 2020908426 @default.
• W2020908426 citedByCount "114" @default.
• W2020908426 countsByYear W20209084262012 @default.
• W2020908426 countsByYear W20209084262013 @default.
• W2020908426 countsByYear W20209084262014 @default.
• W2020908426 countsByYear W20209084262015 @default.
• W2020908426 countsByYear W20209084262016 @default.
• W2020908426 countsByYear W20209084262017 @default.
• W2020908426 countsByYear W20209084262018 @default.
• W2020908426 countsByYear W20209084262019 @default.
• W2020908426 countsByYear W20209084262020 @default.
• W2020908426 countsByYear W20209084262021 @default.
• W2020908426 countsByYear W20209084262022 @default.
• W2020908426 countsByYear W20209084262023 @default.
• W2020908426 crossrefType "journal-article" @default.
• W2020908426 hasAuthorship W2020908426A5008275837 @default.
• W2020908426 hasAuthorship W2020908426A5038787428 @default.
• W2020908426 hasAuthorship W2020908426A5091005335 @default.
• W2020908426 hasBestOaLocation W20209084261 @default.
• W2020908426 hasConcept C126322002 @default.
• W2020908426 hasConcept C126838900 @default.
• W2020908426 hasConcept C134018914 @default.
• W2020908426 hasConcept C15490471 @default.
• W2020908426 hasConcept C170493617 @default.

• next